Natera said on Oct. 9 that the FDA granted Breakthrough Device designation after reviewing data across 12 cancer types; ...

(NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that its multi-cancer early detection (MCED) assay has been granted Breakthrough Device designation (BDD) by ...

Natera's (NTRA) multi-cancer early detection assay has been granted Breakthrough Device Designation by the US Food and Drug Administration, the genetic testing company said Friday ...

A specialized Saudi medical team has begun a complex separation surgery for 13-month-old Moroccan conjoined twins, Saja and Doha, at King Abdullah Specialist Children’s Hospital in Riyadh, following ...

Accepted for Priority Review with a PDUFA target action date of February 4, 2027; being granted Priority Review by the FDA underscores the significant unmet need for an oral targeted therapeutic ...

BridgeBio Pharma, Inc. announced the FDA has accepted for filing its New Drug Application (NDA) with Priority Review for oral infigratinib. The FDA has assigned a Prescription Drug User Fee Act (PDUFA ...

Three scientists were awarded the Nobel Prize in Physiology or Medicine for discoveries that opened up a new era in neuroscience, allowing the mapping of the brain by controlling nerve signals with ...

Reinsurance Group of America upgraded to Buy after strong underwriting and investment returns. See here for a detailed ...

VS3 Medical announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its VS3 System.

EURETINA Innovation Spotlight – Inherited and Rare Retinal Diseases Title: Belite Bio Company Overview Presenter: Hendrik Scholl, M.D., Chief Medical Officer, Belite Bio Date and Time: September 30, ...

Global Medical Device Clinical Trials Market was valued at USD 17.52 Billion in 2025 and is expected to grow at 6.58% CAGR to reach USD 33.14 Billion by 2035.

At Pfizer Oncology, we're focused on improving outcomes for people living with cancer. That means continuing to raise the standard of care today while pursuing the breakthroughs that will shape the ...